As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Subscribe to Curetis Newsletter
Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China
Curetis secures financing facility of up to EUR 20 million through the issuance of convertible notes
Sepsis Day- Lübeck, September 13, 2018
ID Week - Infectious Disease 2018 - San Fransisco, USA - October 3 to 7, 2018